Matt Abernethy - Chief Financial Officer at Neurocrine Biosciences Inc

Insider Transactions and Holdings

Entity Type
Individual
Role
Chief Financial Officer
Stock Symbol
NBIX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
All Insider Reports
All Insider Reports

Matt Abernethy - trading volume in the past year for Neurocrine Biosciences Inc

Holdings reported by Matt Abernethy for Neurocrine Biosciences Inc

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Common Stock 31.5 K $4.42 M $140.24 May 15, 2024 Direct
Non-Qualified Stock Option 15 K $1.1 M $73.60 May 15, 2024 Direct Common Stock
Restricted Stock Unit 8.97 K $388 K $43.24 Feb 13, 2024 Direct Common Stock
Stock Option 45.1 K Feb 13, 2024 Direct Common Stock

Transactions reported by Matt Abernethy for Neurocrine Biosciences Inc

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership